These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1553966)

  • 1. Canadian Hemodialysis Morbidity Study.
    Churchill DN; Taylor DW; Cook RJ; LaPlante P; Barre P; Cartier P; Fay WP; Goldstein MB; Jindal K; Mandin H
    Am J Kidney Dis; 1992 Mar; 19(3):214-34. PubMed ID: 1553966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [REIN Report 2011--summary].
    Couchoud C; Lassalle M; Jacquelinet C
    Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].
    Antonucci F; Camerin E; Feriani M; Nordio M; Piccoli A; Rossi B; Tessitore N
    G Ital Nefrol; 2009; 26 Suppl 48():S5-56. PubMed ID: 19927265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prealbumin and lipoprotein(a) in hemodialysis: relationships with patient and vascular access survival.
    Goldwasser P; Michel MA; Collier J; Mittman N; Fein PA; Gusik SA; Avram MM
    Am J Kidney Dis; 1993 Jul; 22(1):215-25. PubMed ID: 8322786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probability of thrombosis of vascular access among hemodialysis patients treated with recombinant human erythropoietin.
    Churchill DN; Muirhead N; Goldstein M; Posen G; Fay W; Beecroft ML; Gorman J; Taylor DW
    J Am Soc Nephrol; 1994 Apr; 4(10):1809-13. PubMed ID: 8068879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longer-term outcomes of darbepoetin alfa versus epoetin alfa in patients with ESRD initiating hemodialysis: a quasi-experimental cohort study.
    Winkelmayer WC; Chang TI; Mitani AA; Wilhelm-Leen ER; Ding V; Chertow GM; Brookhart MA; Goldstein BA
    Am J Kidney Dis; 2015 Jul; 66(1):106-13. PubMed ID: 25943715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of recombinant human erythropoietin on hospitalization of hemodialysis patients.
    Churchill DN; Muirhead N; Goldstein M; Posen G; Fay W; Beecroft ML; Gorman J; Taylor DW
    Clin Nephrol; 1995 Mar; 43(3):184-8. PubMed ID: 7774076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wasting and sudden cardiac death in hemodialysis patients: a post hoc analysis of 4D (Die Deutsche Diabetes Dialyse Studie).
    Drechsler C; Grootendorst DC; Pilz S; Tomaschitz A; Krane V; Dekker F; März W; Ritz E; Wanner C
    Am J Kidney Dis; 2011 Oct; 58(4):599-607. PubMed ID: 21820222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prealbumin, mortality, and cause-specific hospitalization in hemodialysis patients.
    Chertow GM; Goldstein-Fuchs DJ; Lazarus JM; Kaysen GA
    Kidney Int; 2005 Dec; 68(6):2794-800. PubMed ID: 16316355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood access and daily hemodialysis: clinical experience and review of the literature.
    Kiellstrand CM; Blagg CR; Twardowski ZJ; Bower J
    ASAIO J; 2003; 49(6):645-9. PubMed ID: 14655728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum ferritin is a marker of morbidity and mortality in hemodialysis patients.
    Kalantar-Zadeh K; Don BR; Rodriguez RA; Humphreys MH
    Am J Kidney Dis; 2001 Mar; 37(3):564-72. PubMed ID: 11228181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hospitalization in daily home hemodialysis and matched thrice-weekly in-center hemodialysis patients.
    Weinhandl ED; Nieman KM; Gilbertson DT; Collins AJ
    Am J Kidney Dis; 2015 Jan; 65(1):98-108. PubMed ID: 25085647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing Dialysis Modality and Cardiovascular Mortality in Patients on Hemodialysis and Peritoneal Dialysis.
    Refaat H; Sany D; Mohab A; Ezzat H
    Adv Perit Dial; 2016; 32():22-31. PubMed ID: 28988586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using cuffed and tunnelled central venous catheters as permanent vascular access for hemodialysis: a prospective study.
    Cetinkaya R; Odabas AR; Unlu Y; Selcuk Y; Ates A; Ceviz M
    Ren Fail; 2003 May; 25(3):431-8. PubMed ID: 12803506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietin requirements increase following hospitalization in end-stage renal disease patients.
    Yaqub MS; Leiser J; Molitoris BA
    Am J Nephrol; 2001; 21(5):390-6. PubMed ID: 11684801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular access survival among incident hemodialysis patients in the United States.
    Woods JD; Turenne MN; Strawderman RL; Young EW; Hirth RA; Port FK; Held PJ
    Am J Kidney Dis; 1997 Jul; 30(1):50-7. PubMed ID: 9214401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do cardiac troponins provide prognostic insight in hemodialysis patients?
    Choy JB; Armstrong PW; Ulan RA; Campbell PM; Gourishankar S; Prosser CI; Tymchak WJ
    Can J Cardiol; 2003 Jul; 19(8):907-11. PubMed ID: 12876611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of plasma fibrinogen concentration with vascular access failure in hemodialysis patients.
    Song IS; Yang WS; Kim SB; Lee JH; Kwon TW; Park JS
    Nephrol Dial Transplant; 1999 Jan; 14(1):137-41. PubMed ID: 10052493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between clinical performance measures and outcomes among patients receiving long-term hemodialysis.
    Rocco MV; Frankenfield DL; Hopson SD; McClellan WM
    Ann Intern Med; 2006 Oct; 145(7):512-9. PubMed ID: 17015869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.